Neurocrine Biosciences | DÍVIDA





DÍVIDA Alterar Data
AbbVie USD 1000K 70.48B 2025-09
Acadia Pharmaceuticals USD 56.29M 1.36M 2025-06
Agios Pharmaceuticals USD 48.76M 47.62M 2025-06
ALKERMES USD 72.68M 293.32M 2025-06
Alnylam Pharmaceuticals USD 1.3B 271.5M 2025-06
Amgen USD 54.59B 1.62B 2025-09
Biogen USD 6.29B 309.5M 2025-09
BioMarin Pharmaceutical USD 603.87M 8.22M 2025-06
Cytokinetics USD 858.06M 199.93M 2025-06
Dynavax Technologies USD 285.5M 24.99M 2025-06
Gilead Sciences USD 24.95B 6M 2025-06
Halozyme Therapeutics USD 1.51B 1.65M 2025-06
Incyte USD 42.41M 5.29M 2025-06
Ionis Pharmaceuticals USD 1.23B 192.99M 2025-09
Neurocrine Biosciences USD 439.1M 8.4M 2025-06
Pfizer USD 60.85B 78M 2025-09
Prothena USD 9.08M 699K 2025-09
Regeneron Pharmaceuticals USD 2.71B 400K 2025-09
Repligen USD 533.72M 149.97M 2025-06
Sarepta Therapeutics USD 1.35B 215.59M 2025-06
Teva Pharmaceutical Industries USD 17.07B 450M 2025-09
Ultragenyx Pharmaceutical USD 36.3M 1.98M 2025-06
Vertex Pharmaceuticals USD 1.53B 121.7M 2025-06


Neurocrine Biosciences DÍVIDA - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.